Guidance on PFAS Exposure, Testing, and Clinical Follow-Up.

Format:

Book

Author/Creator:

National Academies of Sciences, Engineering, and Medicine.

National Academies of Sciences, Engineering, and Medicine, author.

Health and Medicine Division, author.

Division on Earth and Life Studies, author.

Board on Population Health and Public Health Practice, author.

Board on Environmental Studies and Toxicology, author.

Committee on the Guidance on PFAS Testing and Health Outcomes, author.

Contributor:

Division, Health and Medicine.

Studies, Division on Earth and Life.

Practice, Board on Population Health and Public Health.

Toxicology, Board on Environmental Studies and.

Outcomes, Committee on the Guidance on PFAS Testing and Health.

Health and Medicine Division, author.

Division on Earth and Life Studies, author.

Board on Population Health and Public Health Practice, author.

Board on Environmental Studies and Toxicology, author.

Committee on the Guidance on PFAS Testing and Health Outcomes, author.

Series:

American Geophysical Union Series

Language:

English

Subjects (All):

Perfluorinated chemicals.

Medical screening.

Physical Description:

1 online resource (301 pages)

Edition:

1st ed.

Place of Publication:

Washington, D.C. : National Academies Press, 2022.

Summary:

In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because they have properties that repel oil and water, reduce friction, and resist temperature changes. PFAS can leak into the environment where they are made, used, disposed of, or spilled. PFAS exposure has been linked to a number of adverse health effects including certain cancers, thyroid dysfunction, changes in cholesterol, and small reductions in birth weight.This report recommends that the Centers for Disease Control and Prevention (CDC) update its clinical guidance to advise clinicians to offer PFAS blood testing to patients who are likely to have a history of elevated exposure, such as those with occupational exposures or those who live in areas known to be contaminated. If testing reveals PFAS levels associated with an increased risk of adverse effects, patients should receive regular screenings and monitoring for these and other health impacts. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up recommends that the CDC, Agency for Toxic Substances and Disease Registry (ATSDR), and public health departments support clinicians by creating educational materials on PFAS exposure, potential health effects, the limitations of testing, and the benefits and harms of testing.

Contents:

Intro

FrontMatter

Reviewers

Acknowledgments

Preface

Contents

Acronyms and Abbreviations

Summary

1 Introduction

2 Principles for Decision Making Under Uncertainty

3 Potential Health Effects of PFAS

4 PFAS Exposure Reduction

5 PFAS Testing and Concentrations to Inform Clinical Care of Exposed Patients

6 Guidance for Clinicians on Exposure Determination, PFAS Testing, and Clinical Follow-Up

7 Revising ATSDR's PFAS Clinical Guidance

8 Implementing the Committee's Recommendations to Improve Public Health

Appendix A: Committee Member, Staff, and Community Liaison Biographies

Appendix B: Summary of the Committee's Town Halls

Appendix C: Public Meeting Agendas

Appendix D: Evidence Review: Methods and Approach

Appendix E: White Paper: Review of the PFAS Personal Intervention Literature.

Notes:

Description based on publisher supplied metadata and other sources.

Part of the metadata in this record was created by AI, based on the text of the resource.

ISBN:

9780309482684

0309482682

9780309482455

0309482453

OCLC:

1342500704